Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 20Urologic Neoplasms 1Urologic Diseases 1Urinary Bladder Diseases 1Transitional Cell Carcinoma of the Bladder 1Non-metastatic Muscle Invasive Bladder Cancer 1Infiltrating Bladder Urothelial Carcinoma 1Cone Dystrophy 3 1Carcinoma, Transitional Cell 1Bladder Adenocarcinoma 1

Interventions

Sunitinib 1Gemcitabine 1Cystectomy 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Transitional Cell Carcinoma of the Bladder × Cystectomy × Clear all
NCT00859339 2016-04-14

Neoadjuvant Cisplatin, Gemcitabine, Sunitinib Malate + Radical Cystectomy for TCC

Hoosier Cancer Research Network

Phase 2 Terminated
9 enrolled 7 charts
Genitourinary

Transitional Cell Carcinoma of the Bladder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡